ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1,3,Headache,Headaches NEC,Headaches,Nerv,N
1,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
3,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
7,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
8,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
10,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
12,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
12,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
12,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
12,4,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
13,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
14,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
15,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
16,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
17,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
20,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
21,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
22,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
22,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
23,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
24,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
25,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
25,2,Palmar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
26,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
26,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
26,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
26,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
26,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
27,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
27,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
27,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
27,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
27,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
28,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
29,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
29,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
30,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
30,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
31,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
31,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
32,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
32,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
32,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
32,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
32,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
33,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
33,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
33,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
33,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
33,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
34,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
35,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
35,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
35,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
36,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
36,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
36,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
37,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
37,2,Headache,Headaches NEC,Headaches,Nerv,N
37,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
37,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,5,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
37,6,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
38,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
38,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
38,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
38,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Application site joint erythema,Application site reactions,Administration site reactions,Genrl,N
39,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
39,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
39,4,Headache,Headaches NEC,Headaches,Nerv,N
39,5,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
39,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
39,7,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
39,8,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
40,1,Application site joint erythema,Application site reactions,Administration site reactions,Genrl,N
40,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
40,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
40,4,Headache,Headaches NEC,Headaches,Nerv,N
40,5,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
40,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
40,7,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
40,8,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
41,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
42,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
43,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
43,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
45,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
